patent/CO-6710915-A2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6710915-A2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate	2013-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce47c00bddfafeb989b1c353046d390b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1503f8a796648f4ccdcce9b61befd957 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c483f6d5c3b1744d702951a88b491036
publicationDate	2013-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CO-6710915-A2
titleOfInvention	Pharmaceutical compositions containing a dgat1 4- (4- (5-6 (- trifluoromethyl-pyridin-3-ylamino) -pyridin-2-yl) phenyl) cycloheiyl) -acetic acid inhibitor or salts thereof
abstract	The present invention relates to a pharmaceutical composition, which comprises: a) a therapeutically effective amount of a compound of the formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, for example 1, 2 or 3, surfactants with lubricating properties; c) one or more, for example 1, 2 or 3, dry binders with non-integrating properties; d) one or more, for example 1, 2 or 3, fillers, and e) one or more , for example 1, 2 or 3, members.
priorityDate	2010-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350

Total number of triples: 36.